Drug Trial Radar · NCT00013520
Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection
Last checked: Nov 19, 2026Latest source record: May 21, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,125
Actual
Start
Not stated
Primary completion
Not stated
Study completion Jun 2005
Sponsor
- Sponsor type
- NIH
- First posted
- Aug 31, 2001
Design
- Study type
- Interventional
- Phase
- Phase 3
- Primary purpose
- Treatment
- Who can join
- All sexes, from 16 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the effectiveness, safety, and tolerability of 3 anti-HIV combination treatments that do not use protease inhibitors (PIs). The current rule for starting treatment of HIV infection is to combine members from different classes of anti-HIV drugs, such as 2 nucleoside reverse transcriptase inhibitors (NRTIs) and either a PI or a nonnucleoside reverse transcriptase inhibitor (NNRTI). However, these combinations can be complicated and difficult to take, can cause a number of side effects, and may become ineffective. Combinations that are simpler, better tolerated, and more effective are needed. Because PIs can cause long-term side effects and because HIV can become resistant to many of them at the same time, anti-HIV combination treatments that do not use PIs are being tested.
Conditions
- HIV Infections
Interventions
Abacavir sulfate, Lamivudine and ZidovudineDrug
AtazanavirDrug
Lamivudine/ZidovudineDrug
Abacavir sulfateDrug
EfavirenzDrug
NevirapineDrug
LamivudineDrug
StavudineDrug
ZidovudineDrug
DidanosineDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
60 sites in 2 countries. Site status is shown where the registry gives one.
Alabama Therapeutics CRS
Birmingham, Alabama
USC CRS
Los Angeles, California
UCLA CARE Center CRS
Los Angeles, California
Stanford CRS
Palo Alto, California
UC Davis Medical Center
Sacramento, California
Univ. of California Davis Med. Ctr., ACTU
Sacramento, California
Ucsd, Avrc Crs
San Diego, California
Ucsf Aids Crs
San Francisco, California
Santa Clara Valley Med. Ctr.
San Jose, California
San Mateo County AIDS Program
San Mateo, California
Willow Clinic A0507 CRS
San Mateo, California
Harbor-UCLA Med. Ctr. CRS
Torrance, California
University of Colorado Hospital CRS
Aurora, Colorado
Georgetown University CRS (GU CRS)
Washington D.C., District of Columbia
Univ. of Miami AIDS CRS
Miami, Florida
The Ponce de Leon Ctr. CRS
Atlanta, Georgia
Univ. of Hawaii at Manoa, Leahi Hosp.
Honolulu, Hawaii
Northwestern University CRS
Chicago, Illinois
Rush Univ. Med. Ctr. ACTG CRS
Chicago, Illinois
Cook County Hosp. CORE Ctr.
Chicago, Illinois
Indiana Univ. School of Medicine, Infectious Disease Research Clinic
Indianapolis, Indiana
Indiana Univ. School of Medicine, Wishard Memorial
Indianapolis, Indiana
Methodist Hosp. of Indiana
Indianapolis, Indiana
Univ. of Iowa Healthcare, Div. of Infectious Diseases
Iowa City, Iowa
Johns Hopkins Adult AIDS CRS
Baltimore, Maryland
Massachusetts General Hospital ACTG CRS
Boston, Massachusetts
Bmc Actg Crs
Boston, Massachusetts
Beth Israel Deaconess Med. Ctr., ACTG CRS
Boston, Massachusetts
Brigham and Women's Hosp. ACTG CRS
Boston, Massachusetts
SSTAR, Family Healthcare Ctr.
Fall River, Massachusetts
University of Minnesota, ACTU
Minneapolis, Minnesota
St. Louis ConnectCare, Infectious Diseases Clinic
St Louis, Missouri
Washington U CRS
St Louis, Missouri
Univ. of Nebraska Med. Ctr., Durham Outpatient Ctr.
Omaha, Nebraska
SUNY - Buffalo, Erie County Medical Ctr.
Buffalo, New York
Beth Israel Med. Ctr., ACTU
New York, New York
Weill Med. College of Cornell Univ., The Cornell CTU
New York, New York
NY Univ. HIV/AIDS CRS
New York, New York
Cornell CRS
New York, New York
Columbia Univ., HIV Prevention and Treatment Medical Ctr.
New York, New York
Showing 40 of 60 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.